Literature DB >> 2681967

Dietary protein restriction in chronic renal failure: an update.

J B Rosman1.   

Abstract

In recent years dietary protein restriction (DPR) to slow down the progression rate of chronic renal disease has been a major field in nephrological science. In this update a brief historical overview is given, as well as a critical review regarding the now available data from clinical trials. Furthermore, the theoretical backgrounds of DPR are discussed. It is concluded that DPR has profound effects on the kidney. In certain diseases, especially primary glomerular disease, the beneficial effect seems proven. However, many questions remain to be answered, e.g. how to apply reliable statistics in chronic renal failure, how to obtain and monitor patient compliance, and the definition of the exact target group since the diet has a selective effect. Most of these questions will be answered in the coming years when data becomes available from large scale multicenter trials. Awaiting these results, proposals for the treatment with diet are made, based on the facts that are now to our knowledge.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681967     DOI: 10.1007/bf01717344

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  24 in total

1.  Two years' experience with protein restriction in chronic renal failure.

Authors:  J B Rosman; A J Donker; S Meijer; W J Sluiter; T P Piers-Becht; G K van der Hem
Journal:  Contrib Nephrol       Date:  1986       Impact factor: 1.580

2.  Dietary treatment of chronic renal failure: ten unanswered questions.

Authors:  A M el Nahas; G A Coles
Journal:  Lancet       Date:  1986-03-15       Impact factor: 79.321

3.  A simple method of estimating progression of chronic renal failure.

Authors:  W E Mitch; M Walser; G A Buffington; J Lemann
Journal:  Lancet       Date:  1976-12-18       Impact factor: 79.321

4.  Restricted phosphorus and nitrogen intake to slow the progression of chronic renal failure: a controlled trial.

Authors:  G Barsotti; E Morelli; A Giannoni; A Guiducci; S Lupetti; S Giovannetti
Journal:  Kidney Int Suppl       Date:  1983-12       Impact factor: 10.545

5.  Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate.

Authors:  J H Bauer; C S Brooks; R N Burch
Journal:  Am J Kidney Dis       Date:  1982-11       Impact factor: 8.860

6.  Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications.

Authors:  J B Rosman; K Langer; M Brandl; T P Piers-Becht; G K van der Hem; P M ter Wee; A J Donker
Journal:  Kidney Int Suppl       Date:  1989-11       Impact factor: 10.545

7.  Prospective randomised trial of early dietary protein restriction in chronic renal failure.

Authors:  J B Rosman; P M ter Wee; S Meijer; T P Piers-Becht; W J Sluiter; A J Donker
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

Review 8.  Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.

Authors:  B M Brenner; T W Meyer; T H Hostetter
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

9.  Phosphate depletion arrests progression of chronic renal failure independent of protein intake.

Authors:  D Lumlertgul; T J Burke; D M Gillum; A C Alfrey; D C Harris; W S Hammond; R W Schrier
Journal:  Kidney Int       Date:  1986-03       Impact factor: 10.612

10.  Answers to ten questions on the dietary treatment of chronic renal failure: On behalf of the Steering Committee of the European Study Groups for the Conservative Treatment of Chronic Renal Failure.

Authors:  S Giovannetti
Journal:  Lancet       Date:  1986-11-15       Impact factor: 79.321

View more
  1 in total

Review 1.  Do glomerular hemodynamic adaptations influence the progression of human renal disease?

Authors:  A S Woolf; L G Fine
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.